Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.170
+0.010 (0.86%)
Jul 31, 2026, 4:08 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.37 billion as of July 31, 2026. Its market cap has decreased by -29.38% in one year.
Market Cap
2.37B
Enterprise Value
3.08B
Revenue
2.00B
Ranking
n/a
PE Ratio
45.57
Stock Price
1.17
ChartMarket Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.37B, a decrease of -64.73%. That is a compound annual growth rate of -13.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.37B | 17.00% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HJ Science | 3.04B |
| Shandong Boan Biotechnology | 2.92B |
| Beijing Luzhu Biotechnology | 2.78B |
| TYK Medicines | 2.73B |
| Antengene Corporation | 2.63B |
| Viva Biotech Holdings | 2.61B |
| BioDlink International Company | 2.49B |
| Laekna | 2.29B |